Insider · CIK 0001215024
R John Fletcher
directorother
Files at KRMD (KORU Medical Systems, Inc.), CLPT (ClearPoint Neuro, Inc.), OPTN (OptiNose, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CLPT ClearPoint Neuro, Inc. | AGrant or award Common Stock | +993 | $12.21 | $12k | 132,004 | 10 d ago |
| Oct 1, 2026 | KRMD KORU Medical Systems, Inc. | AGrant or award Common Stock | +7,679 | $2.93 | $22k | 239,836 | 11 d ago |
| May 22, 2025 | CLPT ClearPoint Neuro, Inc. | AGrant or award Restricted Stock Unitsderivative | +12,417 | $0.00 | $0 | 12,417 | May 23, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,666 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,566 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,266 | - | - | 0 | May 21, 2025 |
| May 16, 2025 | CLPT ClearPoint Neuro, Inc. | MOption exercise Common Stock | +21,093 | - | - | 115,491 | May 19, 2025 |
| May 16, 2025 | CLPT ClearPoint Neuro, Inc. | MOption exercise Restricted Stock Unitsderivative | -21,093 | - | - | 0 | May 19, 2025 |
| Apr 2, 2025 | KRMD KORU Medical Systems, Inc. | AGrant or award Common Stock | +8,806 | $2.56 | $23k | 205,562 | Apr 2, 2025 |
| Apr 1, 2025 | CLPT ClearPoint Neuro, Inc. | AGrant or award Common Stock | +486 | $11.89 | $5,779 | 94,398 | Apr 2, 2025 |
| Jan 3, 2025 | KRMD KORU Medical Systems, Inc. | AGrant or award Common Stock | +5,905 | $3.81 | $22k | 196,756 | Jan 3, 2025 |
| Jan 2, 2025 | CLPT ClearPoint Neuro, Inc. | AGrant or award Common Stock | +375 | $15.38 | $5,768 | 93,912 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.